Dynavax Technologies Corp (NASDAQ:DVAX) shares, rose in value, with the stock price up by 2.11% to the previous day’s close as strong demand from buyers drove the stock to $14.31.
Actively observing the price movement in the recent trading, the stock is buoying the session at $14.01. The PE ratio was 81.88 over 12-month period. Referring to stock’s 52-week performance, its high was $14.11, and the low was $9.74. On the whole, DVAX has fluctuated by 10.04% over the past month.
With the market capitalization of Dynavax Technologies Corp currently standing at about $1.77 billion, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 326.35M, with a low estimate of 66.59M and a high estimate of 76M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 70.01M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DVAX’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.48, with the price of DVAX currently trading nearly 7.39% and 10.09% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 71.50, while the 7-day volatility ratio is showing 3.02% which for the 30-day chart, stands at 3.14%. Furthermore, Dynavax Technologies Corp (DVAX)’s beta value is 1.25, and its average true range (ATR) is 0.43.
A comparison of Dynavax Technologies Corp (DVAX) with its peers suggests the former has fared considerably weaker in the market. DVAX showed an intraday change of 2.11% in today’s session so far, and over the past year, it grew by 12.28%%. Additionally, there is a gain of 0.74%% for Pfizer Inc. (PFE) in recent trading while the stock has seen an overall depriciation of -3.17%% over the past year.
Data on historical trading for Dynavax Technologies Corp (NASDAQ:DVAX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.72 million. According to company’s latest data on outstanding shares, there are 125.45 million shares outstanding.
Nearly 4.43% of Dynavax Technologies Corp’s shares belong to company insiders and institutional investors own 101.93% of the company’s shares. The stock has risen by 12.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DVAX stock heading into the next quarter.
